Literature DB >> 16282323

Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function.

Xiao-Jun Qi1, Gary M Wildey, Philip H Howe.   

Abstract

Bim, the Bcl-2 interacting mediator of cell death, is a member of the BH3-only family of pro-apoptotic proteins. Recent studies have demonstrated that the apoptotic activity of Bim can be regulated through a post-translational mechanism whereby ERK phosphorylation serves as a signal for Bim ubiquitination and proteasomal degradation. In this report, we investigated the signaling pathways leading to Bim phosphorylation in Ba/F3 cells, an interleukin-3 (IL-3)-dependent B-cell line. IL-3 stimulation induced phosphorylation of Bim(EL), one of the predominant isoforms of Bim expressed in cells, at multiple sites, as evidenced by the formation of at least three to four bands by Western blotting that were sensitive to phosphatase digestion. The appearance of multiple, phosphorylated species of Bim(EL) correlated with Akt, and not ERK, activation. The PI3K inhibitor, LY294002, blocked IL-3-stimulated Akt activity and partially blocked Bim(EL) phosphorylation. In vitro kinase assays showed that recombinant Akt could directly phosphorylate a GST-Bim(EL) fusion protein and identified the Akt phosphorylation site in the Bim(EL) domain as Ser(87). Further, we demonstrated that cytokine stimulation promotes Bim(EL) binding to 14-3-3 proteins. Finally, we show that mutation of Ser(87) dramatically increases the apoptotic potency of Bim(EL). We propose that Ser(87) of Bim(EL) is an important regulatory site that is targeted by Akt to attenuate the pro-apoptotic function of Bim(EL), thereby promoting cell survival.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282323     DOI: 10.1074/jbc.M505546200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  108 in total

1.  Akt2: a critical regulator of cardiomyocyte survival and metabolism.

Authors:  Anthony J Muslin
Journal:  Pediatr Cardiol       Date:  2011-01-30       Impact factor: 1.655

2.  Alternative splicing of Bim and Erk-mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis in vivo.

Authors:  C Clybouw; D Merino; T Nebl; F Masson; M Robati; L O'Reilly; A Hübner; R J Davis; A Strasser; P Bouillet
Journal:  Cell Death Differ       Date:  2012-01-13       Impact factor: 15.828

3.  Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth.

Authors:  Yaxiong Tang; Xuesen Li; Zhongbo Liu; Anne R Simoneau; Jun Xie; Xiaolin Zi
Journal:  Int J Cancer       Date:  2010-10-15       Impact factor: 7.396

4.  Cyclic-AMP-dependent protein kinase A regulates apoptosis by stabilizing the BH3-only protein Bim.

Authors:  Diane Moujalled; Ross Weston; Holly Anderton; Robert Ninnis; Pranay Goel; Andrew Coley; David C S Huang; Li Wu; Andreas Strasser; Hamsa Puthalakath
Journal:  EMBO Rep       Date:  2010-12-10       Impact factor: 8.807

5.  Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function.

Authors:  Samir M Abdelmagid; Gregory R Sondag; Fouad M Moussa; Joyce Y Belcher; Bing Yu; Hilary Stinnett; Kimberly Novak; Thomas Mbimba; Matthew Khol; Kurt D Hankenson; Christopher Malcuit; Fayez F Safadi
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

6.  Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance.

Authors:  James A McCubrey; Linda S Steelman; Richard A Franklin; Steven L Abrams; William H Chappell; Ellis W T Wong; Brian D Lehmann; David M Terrian; Jorg Basecke; Franca Stivala; Massimo Libra; Camilla Evangelisti; Alberto M Martelli
Journal:  Adv Enzyme Regul       Date:  2007-03-26

Review 7.  Ubiquitin-proteasome system as a modulator of cell fate.

Authors:  Simon J Thompson; Liam T Loftus; Michelle D Ashley; Robert Meller
Journal:  Curr Opin Pharmacol       Date:  2007-11-05       Impact factor: 5.547

Review 8.  Involvement of Akt in neurite outgrowth.

Authors:  Danielle E Read; Adrienne M Gorman
Journal:  Cell Mol Life Sci       Date:  2009-06-06       Impact factor: 9.261

Review 9.  Molecular and cellular mechanisms of CLL: novel therapeutic approaches.

Authors:  Lisa Pleyer; Alexander Egle; Tanja Nicole Hartmann; Richard Greil
Journal:  Nat Rev Clin Oncol       Date:  2009-06-02       Impact factor: 66.675

10.  Contrasting patterns of Bim induction and neuroprotection in Bim-deficient mice between hippocampus and neocortex after status epilepticus.

Authors:  B M Murphy; T Engel; A Paucard; S Hatazaki; G Mouri; K Tanaka; L P Tuffy; E M Jimenez-Mateos; I Woods; M Dunleavy; H P Bonner; R Meller; R P Simon; A Strasser; J H M Prehn; D C Henshall
Journal:  Cell Death Differ       Date:  2009-09-25       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.